Astero

Skin Tears Treatment Market to Observe Strong Development by 2018-2026

[To download a printable version of this article, click here] MARKET RESEARCH April 12, 2019 / kalyani badkas Skin tears have become a common issue among people of older age as the skin becomes more delicate and drier and so skin tears treatment has become an...

The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Debridement and Wound Pain Management

Astero® provides fast relief for painful wounds as fast as 3-5 minutes. Available by prescription only, Astero® is indicated for the relief of painful wounds and wound healing such as ulcerations, pressure wounds, first and second degree burns, post-surgical...

Now Available Through Federal Supply Schedule (FSS)

Contract #V797D-70219 The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Pain Associated with Wound Healing and Vasculitis FDA Approved #K092086 Astero®, manufactured by Gensco Pharma, is now available through the Federal Supply Schedule. Astero®...

Advances in Treatment of Painful Wounds

by Marc Alan Brenner, DPM, The Institute for Diabetic Foot Research As seen in Podiatry Management | November 2016 Wound management is one of the most common aspects of podiatric practice. The etiology of the wound may vary from post-surgical, traumatic, or disease...

Gensco’s Astero hydrogel alleviates diabetic foot ulcers

As seen in Chain Drug Review’s Diabetes Care Report.
Approximately 15% of people with diabetes suffer from foot ulcers, and treating them properly can be challenging for the patient. However, failure to do so, with resulting infection, carries the danger of eventual amputation.

Skin Tears Treatment Market to Observe Strong Development by 2018-2026

The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Debridement and Wound Pain Management

Now Available Through Federal Supply Schedule (FSS)

Advances in Treatment of Painful Wounds

Gensco’s Astero hydrogel alleviates diabetic foot ulcers

LOOKING TO THE FUTURE